Saturday, March 11, 2006

biotech news - IPIFINI's Founder to Present on Starting a Biotech Without Venture Funding



http://www.arizonabiotech.com/
http://groups.yahoo.com/group/biotech-news/
http://www.arizonaentrepreneurs.com/
http://www.azhttp.com/



Yahoo! Groups My Groups | biotech-news Main Page

biotech news - IPIFINI's Founder to Present on Starting a Biotech Without Venture Funding at IBC's DRUG DISCOVERY TECHNOLOGY(R) Europe Conference
Friday March 10, 10:00 am ET

 
 
IPIFINI, Inc. announced today the Company will present at IBC's DRUG DISCOVERY TECHNOLOGY® Europe conference. Tod Woolf, Ph.D., President, will provide a case study describing the founding of his prior company, Sequitur, entitled, "$20,000 and a Dream: The Agony and the Ecstasy of Starting a Biotech Without Venture Funding."

The presentation will begin at 10:30 AM (GMT) on Wednesday, March 15, 2006.

Dr. Woolf founded Sequitur in 1997 in Natick, Massachusetts. Sequitur grew sales to over $5,000,000 a year with $20,000 in total equity financing and was profitable for seven years as an independent company. Sequitur was acquired by Invitrogen in 2003. The hiring strategies, contract manufacturing, systematic R&D methodologies and business development strategies that permitted this organic growth will be discussed.

About IPIFINI, Inc.

IPIFINI is a Massachusetts-based technology development corporation founded in 2003. IPIFINI provides technology and business development advisory services focusing on the biomedical and consumer products areas. IPIFINI employs its award winning Innovation Engine(TM) idea generation software to generate Intellectual Property (IP) for new products. IPIFINI's clients include technology-driven companies such as Praecis Pharmaceuticals, Signet Laboratories and Invitrogen.

IPIFINI is a registered Service Mark and Innovation Engine is a trademark of IPIFINI, Inc.

Web site: http://www.ipifini.com

http://groups.yahoo.com/group/biotech-news/


 


Source: IPIFINI, Inc.



YAHOO! GROUPS LINKS




0 Comments:

Post a Comment

Links to this post:

Create a Link

<< Home